Unless you borrow money to invest, the potential losses are limited. But if you pick the right stock, you can make a lot more than 100%. For example, the Imagion Biosystems Limited (ASX:IBX) share ...

Imagion Biosystems Limited (ASX:IBX) shareholders have seen the share price descend 13% over the month. But in three years the returns have been great. In three years the stock price has launched 113% ...

Pitt Street Research says Imagion is significantly undervalued and sits around 75-80% below target range of 12.3 to 14.9 cents per share Research house sees even upside if MagSense imaging agent tech ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Manufacturing completed on Imagion’s MagSense HER2 breast cancer imaging agent for its Phase II clinical trial Imagion, Siemens and Wayne Street University AI imaging protocol optimisation ...

Imagion Biosystems Ltd. (AU:IBX) has released an update. Imagion Biosystems Limited has announced a proposed issue of up to 9,375,000 new securities, including 3,125,000 options and 6,250,000 fully ...

Imagion Biosystems, Ltd. (ASX: IBX) announced that it has secured firm commitments for AU$3.75M (US$2.59M) in new capital following the FDA’s clearance of the company’s IND application for a Phase 2 ...